Welcome, everyone, to day two of the Stephens 2026 Annual Investment Conference, live and in person in Nashville. I am Raj Kumar, Healthcare Services Analyst with Stephens. Next up, we have The Ensign Group, a leading provider of skilled nursing care across the U.S. Joining us here from Ensign today are Barry Port, Chairman and CEO, and Chad Keetch, Executive Vice President and Chief Investment Officer. I want to thank you both for joining us here today at the conference, and I think we will jump right into Q&A if that sounds good with you all.
That is great.
Awesome. To start, great year from a fundamental perspective for Ensign, continued kind of beat and raise cadence. Although, there has been some external factors that maybe have weighed on the stock, kind of thinking about short reports, acute care volume commentary around surgical volumes. But would love to kind of get your perspective as you kind of start closing out in 2026. How do you kind of view the operational milestones and results achieved kind of relative to your internal expectations?
Yeah, I mean, having external noise is always an opportunity, I think, to just sort of self-examine. But it certainly did not change our conviction in the model. It gives us another opportunity, I think, to prove it. And I think you have kind of seen a little bit how we have decided to present ourselves. I think historically, we have made a conscious decision to just sort of be maybe a little bit more private about touting how good we do in one particular area or another, especially when it comes to quality.
But at the end of the day, I think that is one of the lessons learned is, we need to tell our story more boldly and more broadly and make sure that we show to the world what our affiliates not only are capable of doing, but what they have done to really transform the industry in a meaningfully positive way.
When you look at our results through the first nine months, we have seen really great revenue growth, almost 17% revenue growth, EBITDA growth of 21.5%, and adjusted net income growth of almost 24% over last year. That is in the midst of doing a lot of acquisitions. Since the beginning of 2025, our portfolio has grown by. That growth makes up 20% of our portfolio.
There is just a lot of organic upside, especially when you consider a lot of those recently acquired operations are very immature in their stage of development with us. We are also, I think, driven to lean heavily, as you have heard us do more on our investor calls and then also in our website and our investor presentations. We are leaning heavily on touting our clinical expertise and outcomes.
I mean, our surveys are 15% better than our peers in the states that we operate in. From a quality measure standpoint, we are better than the national average on all 15 out of 15 quality measures. We are better than our peers by 21% when it comes to quality measures.
Our number of high-performing facilities, that recent designation that CMS came out with, 12% of our operations were designated, of our eligible operations, were designated with that high-performing designation, which is almost double of any of our peers that are growing SNF companies. That is something we are proud of and something you will hear us talk a lot more about. Our outcomes are at the heart and the core of why we have been able to achieve the outcomes we have been able to.
Got it. I think some of the core pillars of Ensign and the operating model you guys have highlighted is just the locally led operations, which drive underlying performance. I think something that I would love to touch upon is just the service center itself, which is the connecting body across all the operations. Ensign has accelerated immensely from an M&A perspective across 2024, 2025, and 2026. As we think about acceleration, how has the service center evolved to maintain pace with the acquisition portfolio, and maybe what has meaningfully changed to drive durability while you guys scale?
Yeah, I can take that one. When we say service center, essentially you can think of all the back office functions that are necessary to ultimately deliver the best service we can at the local level. If you think of things like accounting services, financial systems, IT, which is obviously a more increasingly important part of delivering healthcare and having the technology and resources available that the field needs.
A compliance team. We have the best and most sophisticated compliance support in the industry. Invested enormous amounts of capital, both human and actual capital to that. HR and making sure we have all the best practices in place from that point of view. Legal, I mean, this is an industry where we get sued from time to time and having the best, most competent attorneys that you could hope for in the fold.
Then you could even acquisitions and real estate and licensing and some of that stuff is also important too. With all that said, we certainly have, as we've gotten bigger, we haven't changed the core principle of local accountability and locally led operations are at our core. The service center exists to support the field, and we are passionate and almost fanatical about the fact that as we grow, that we make sure that is never lost, that that focus is that we have jobs at the service center because the field is existing and providing care at the patient level. But the beauty of our model is you sort of get the benefit of that local approach. This is the most local business you could ever have with the benefit of the scale.
Having the size of our consolidated group to invest in things like back office systems and IT and compliance, all those things I mentioned, with that local approach has really become a differentiating factor for us. As we continue to grow, I think it's really important that we have that scale. I think one of the things that's most common that we see in folks that are deciding to sell their business is you get to a certain size, 20, 30 buildings, and you either have to grow through that or you kind of have to decide to sell.
We're seeing increasingly a number of portfolios like that, and we have that back office support in place that makes that really doable for us and makes it really comfortable for us to support the field as they continue to find and decide to grow in that way. It's really an important part of our story, I think, that is underappreciated. I mean, we have the smartest team. It's really just remarkable. I'm just thinking of people that are at the service center that are truly experts in every aspect of our business, and I know the field appreciates that a lot. There's probably not a question that they have or a problem that they have that they can't get support from the service center to help them with.
It makes their jobs a lot easier, and they can focus on the things at the facility level that matter most.
Got it. As we kind of maybe kind of thinking about the buckets of operations as you kind of highlight them when you release is across mature, transitioning, and newly acquired. I want to focus on the kind of the mature facilities. Clearly, they provide a really healthy baseline of growth in this mid-single-digit range. It would be helpful to maybe parse out kind of occupancy and skilled mix kind of performance between your upper quartile and lower quartile facilities, just to maybe help illustrate that you could still kind of sustain mid-single-digits type of top-line growth in that even most mature bucket.
Yeah, I mean, I think probably one of the more underappreciated things is that the only special thing about same-store designation as far as how we define our buckets, and perhaps there's some other ways we can highlight this, but is that they've reached three years of operations with us, right? But within that cohort, you have some buildings that we've had three years, and you've had some that we've had almost 30. The level to which buildings kind of progress across that timeframe is vast. I mean, one thing to think of is almost 20% of that same-store bucket is at 74% occupancy or less, right? So, with our average occupancy in that bucket being 84% and change, one in five buildings just to get to the average has just a ton of upside.
I think too, if you look at our top-performing buildings in that bucket, I mean, these are buildings that are generally in the mid- to high- 90% range. But as they reach capacity, their acuity shift just constantly continues to evolve and change as well. I mean, we have buildings that reach 70% and 80% skilled mix in terms of days that are in that bucket that once started at 10%, right?
So, we share some data with you in our investor presentation that I think shows this a little more clearly in how things kind of evolve from its first five quarters to when a building hits 15 quarters to when it hits 45 quarters. So, at like 10- 11 years, buildings have EBITDA improvement of almost 60% from after the first five quarters. So, that improvement continues across a long period of time.
Just, hopefully those things kind of demonstrate. There's just, even in that bucket alone, there's a ton of upside.
Got it. Skilled mix is an important factor in terms of the kind of differentiated services that you guys provide within your four walls. As we kind of think about where that metric is for the same-store book, kind of hitting near the pandemic levels that were had tailwinds from COVID waiver and public health emergency kind of waiver programs in place. How should we kind of think about, is that pandemic era kind of a ceiling or there's still much more optimization? You clearly highlighted some are skilled mix in the 70%-80%, but not every market is like that. As we kind of think about.
Yeah.
The progression of skilled mix.
Yeah, I mean, look, in same-store alone, quarter-over-quarter, I think there's 170 basis points of improvement on skilled mix. Look, remember, skilled mix isn't the only lever for same-store buildings either. I mean, there's changes in acuity and service offerings and clinical programs and reimbursement. There's other things that happen there. I think what's important for you to recognize is we look at buildings and underwrite them. We're not underwriting, how do we get these to 100% occupancy? The underwriting thesis for us is always, where will continuous improvement come from? Understanding that buildings will continue to evolve even when they hit 10 years and 15 years and 20 years. We see that. We try to highlight those in our earnings calls too.
We show buildings that we've had for 15 years that continue to shift their service offerings and see acuity continue to grow and evolve and take higher rate reimbursement sources and bring on programs like the VA and skilled Medicaid programs. The opportunities are endless. There's even buildings that hit that capacity. We look at things like bed expansions. We have about 40 of our buildings that are kind of in that category of high to mid-90% range in terms of occupancy that we're doing analysis on for bed expansion.
About a quarter of those we're already doing drawings and designs for the bed expansion. Because we own a lot of our real estate, it's sort of an easy, natural endeavor and extension to do that to the extent that we have land and an ability to do that. So that's another lever there.
Great. Maybe I will pause right here to see if we have any questions from the audience.
Maybe, while you are on that point about the owning the real estate, how do you guys think about? You have a big portfolio of buildings, properties.
Yeah.
In your control and without any debt on them, right?
Okay.
Yeah, I mean, we always would like to remind folks that where we can, we want to own it and operate it. I mean, we are definitely operators first, but throughout the years, we have been able to generate hundreds of millions of dollars of value in the real estate itself. And if you think about a skilled nursing facility, it sort of is what it is. It is not going to get repurposed into some other use. The value of the underlying real estate is so closely connected to the operations.
So when you take something that is low occupancy, low skilled mix, sometimes even losing money, bad clinical reputation, if you change all those things, that property, the underlying real estate is worth more. So, over time, we have acquired around 200 of our 418 assets are owned.
Most of those, I think, call it 2/3 of them are completely debt-free, have absolutely no leverage on them at all. There's lots of things we can do to unlock that, but the one that just kind of stands out is probably the easiest, you can take those assets and go to HUD, for example, and you can get a loan on that, let's call it 70% loan to value, using kind of the current market value. If we paid $60,000 a bed for something that's now worth $200,000 a bed, you can just figure out how you can sort of extract some of that value and put it on the balance sheet in a way to help fund other growth. So that's one of many levers that that gives us.
But it also, to Barry's point about bed expansions, when you own the asset and you want to do something like add 40 beds to it, when you own it's one less hurdle you have to jump over. We have landlords that want to cooperate and do that too, but of course, they have a spread that they're going to try to make on you doing that too. But, in either case, I think we're really excited about the prospects that we have to continue to buy and create value in the real estate. Our balance sheet is as healthy as ever, and the dry powder we have to do that is significant.
All right. As we kind of think about clinical outcomes, clearly it's an important part of the story. The team has highlighted it more and more as the quarters progress. How would you characterize that kind of opportunity on still proving the clinical or showcasing the clinical outcomes to, say, managed care partners? When we think about from an M&A perspective, where these are typically distressed or underperforming facilities that don't necessarily have the greatest clinical scores. What does that turnaround look like to kind of reach towards Ensign or level or mature level facility KPIs?
Yeah, I mean, look, I think this probably makes sense to everyone here, but quality is what really drives our economic model. I mean, make no mistake about it, we are in an age where it's virtually impossible to influence discharge decisions from a hospital by showing up with cute marketing materials and donuts or something like that, right? I mean, they're financially incentivized, as we are, to drive outcomes. So readmission rates and lengths of stay really matter to acute hospitals and managed care providers. So, at the core of everything we do as operators, we're thinking about how to drive that first and foremost.
It's a shortsighted endeavor to just think, "How do I move census today?" Our operators are uniformly focused on, "How do I make sure I have the right staff focused on the right things, making the right decisions at the bedside every day to ensure that patients receive the care they need and get home when they need to get home?" I think that's an important aspect of how to frame how we see the business.
I mean, we've seen that as better outcomes happen, it builds more trust from the hospitals and managed care partners, and that translates into more referrals and more admissions and ultimately more census, and it's as simple as that. For us, it plays out in the numbers. I mean, we saw Medicare increase by almost 8% year-over-year on a same-store basis, and managed care about 3%.
The mix of those two things is less important to us as it is that benchmark of improvement where we're seeing skilled census continue to grow every quarter. That's, fortunately, what we've been able to see as kind of one of the main themes of our improvement story over the last several years, is we continue to gain more and more confidence from our acute partners and from our managed care partners.
Got it. There's a clear volume component to it, as you kind of spoke to the kind of referral benefits. As we kind of think about maybe on the reimbursement side, managed care typically kind of underpays to fee-for-service, and there's always kind of been the kind of debate about closing that discount gap. Where does that kind of stand? Is it still early in that opportunity as we kind of think about maybe even being like a provider of choice that can also garner a higher rate relative to the typical discount?
Yeah, I mean, look, I think it's important to understand that, yeah, higher quality certainly ultimately translates to, I think, higher rate opportunities. But I think for us, we are sort of payer agnostic when it comes to skilled payers. I mean, yes, traditional fee-for-service have slightly better margins, but it's not always simple as looking at the rate and comparing rates, right? There are things that managed care will carve out and pay for that on a fee-for-service patient, you have no exceptions for that, right? So, high-cost meds or some of the DME that's required for patient care, sometimes plans will pay for that, and Medicare won't.
So, it's not really an apples- to- apples comparison when you just look at rates. I think suffice to say for us, as we embrace all skilled payers, they're all certainly a higher margin profile on both payer types.
But I think also importantly, it fits kind of what we're trying to accomplish. We are trying to, as we look at the landscape and look many years ahead and see kind of what the demographics will ultimately shift to. Today, we're talking about how to make incremental census gains, but five to eight years from now, overall census won't be the differentiator. What will be the differentiator is where will the trust fall for the higher acuity patients? And that's where the scrutiny will continue to escalate, and providers that can do that successfully are going to be the ones that set themselves apart from the rest of the industry.
That's where we're focused, is on how to make sure that as this patient cohort of 80+ year-olds continues to grow, we know a good chunk of those are going to be really, really acute and really sick and have different needs, and we want to be able to fill those needs. So, we've been making heavy investments into physician networks and how we look at the patient experience even after they leave our facilities, looking at things like remote patient monitoring and outpatient therapy programs to help them continue to thrive at home. Because at the end of the day, we want to be the most successful at ensuring that those outcomes are durable.
And I'll just add, when you're comparing Medicare to managed care patients, being a preferred provider, as you mentioned, is a big deal. Even if there is pressure on the length of stay, the benefit to it is they reward you with volume. And that's a really nice thing as you operate a building, because there's some predictability that comes with that, and that patient flow and understanding the acuity of those patients. It's not uncommon for us to have managed care case managers have offices and be present in our buildings. And the level of partnership with those folks can be a real advantage as we're navigating the flow of patients and how to plan for it, how to staff for it, all those things, so.
Got it. Clearly, we talked about same-store here, but kind of moving on to the acquisition pipeline, which is the most significant call option that Ensign has in terms of expanding its story and its kind of values to the broader healthcare continuum, skilled nursing continuum. As I kind of think about, Chad, I think you've talked about, you guys are very comfortable with doing 50- 60 acquisitions annually, but that's not like a hard target. It's always based on the opportunity. But maybe talk to the leadership pipeline. Clearly, that's the most important aspect of driving M&A. What have been the constraints historically, and kind of how Ensign has kind of solved for those constraints?
Yeah. As you mentioned, our balance sheet and our availability of capital has never been a constraint for us to do deals, nor has the pipeline, frankly. This year, we've announced 45 additional new operations that we're adding, but we probably evaluated, underwrote, looked at something like 400. Just to give you a sense, if we wanted to double and triple in size, there's opportunity to do that. The question is, okay, when do you decide to do a deal or not? And the very first question we ask is, who's going to lead it? Who's going to be the person that, if this is a broken building clinically, financially, and culturally, it's going to need a new leader.
I think the thing that is really exciting to us is that there's a lot of momentum around our story, and we have a lot of folks that really come from other walks of life, different industries, professionals that have done other things, and this is sometimes a second and even a third career opportunity for these folks. Most often, they know somebody that has come to us, and they've seen how successful they are and how happy they are. There is a long line of folks that are looking to join and become an administrator in training. On average, these are not fresh out of undergrad. These are folks that the average age of an AIT for us is 35 years old, just to give you an idea on that.
Every market has an incentive, right, to make sure they have people in the pipeline that can do a deal, because when one comes, they know the question is, who's your leader? There's been many times where we've said no to an opportunity that on paper looks great because we don't have that leader. Sometimes that's the best lesson for a market to learn is, well, gosh, I wish I could have done that, but I didn't have someone in the pipeline. You see that kind of, I won't say peer pressure, but sort of just this element of understanding that we've got to be ready when those opportunities come. That's a constant focus. Our market leaders are always looking and trying to recruit those folks.
In any given month, we may have a dozen or so folks that have been through multiple levels of interviews that want to become part of the program, and maybe two or three of those get offers. We're able to be really selective. Feels like it's an unlimited kind of pool of folks because we're just not pulling people straight from the industry that are already licensed. That's one of our main focuses.
But the other thing that I think we've become better at over time, because we've done some larger deals that have more of a quality history and clinical strength especially, we've found that oftentimes, we can take an existing leader in place that has led a strong culture and fold them into kind of the Ensign approach, and we've done that very successfully as well.
Using some examples, we did a couple deals in California recently that were larger portfolios, and we probably kept a half, even a little bit more than half of the existing leaders in place in those buildings that we saw. This is all kind of pre-acquisition.
We are able to sit down, evaluate, interview, get to know these folks, and oftentimes they are kind of itching to sort of approach it the way we do, which is, again, this locally led approach that they are empowered and put in a cluster to lead their building in the way that they would like to. Sometimes they feel this sense of, man, a lot of red tape that maybe I had with the prior owner. All these things I want to do, Ensign is telling me I can do.
We get a lot of excited folks that are really talented and ready to join us. That is another thing that we have been able to do a lot better is integrate some really strong leaders that already are present into our growth model. Really excited about it. I mean, 50-60 acquisitions in a year is comfortable. Like you said before, having the service center sort of scaling behind that too, there is no shortage of opportunity, and we feel like we are building a really strong bench to continue the pattern we have been on.
Got it.
Yeah, just to add real quick, we have done this with several of our portfolio deals recently where we have kept a decent number of those leaders, and bringing them on early and putting them in through an Ensign indoctrination program, it has proven out in the numbers too.
Because we are leadership-driven first, our deliberate approach to kind of identifying the right ones that we want to keep and train them and kind of surrounding them in a cluster with experienced Ensign leaders that know our model, even though they might have less tenure in the role as these ones that we are taking on, knowing our model, our peer accountability system, our shared incentives, our growth mindset, has been really important. Having the dual lever approach of both AITs and taking on existing leaders, we do that and still have industry-leading turnover.
In the states we operate in, we have 45% better administrator turnover than all of our peers.
Got it. As we kind of come up on time here, maybe would love to just kind of get your thoughts on, as we kind of think about the Ensign story, what do you feel is the most kind of under the radar as we kind of think about the long-term earnings power of the business? Then, which one of the investments that we've kind of gone through today will have the kind of largest impact to driving or capturing that earnings power?
Yeah, I think it's probably a combination of the fact that our pipeline of opportunities is, number one, it's very, very exciting to us. We're working on a lot of different deals that we feel really, really good about. It's a mix of turnarounds and also maybe higher performing, but nicer physical plant operations that we might pay a little bit more for. Combined with the fact that, just from an organic standpoint, knowing that almost a quarter of our portfolio is brand new and has just so much organic upside, including those that are in our same-store bucket. I think the fact that there's so much opportunity in those two things combined gives us a lot of confidence about where we're headed.
Great. Any questions from the audience? All right, that wraps us up. Thank you very much for joining us.
Thanks.
Thanks, everybody.